Business · 01/08/2019

FDA Releases Draft Guidance on Neonatal Clinical Pharmacology Considerations for New Drug Applications

The Food and Drug Administration (FDA) has made available a draft guidance document to help pharmaceutical companies prepare for clinical studies involving newborns, as required by the FDA Reauthorization Act of 2017